The life-sciences press is peppered with headlines such as 'Court holds that Ranbaxy did not infringe GSK patent' and 'Court awards Applied Medical Resources Corp., $43.5 million because Tyco Corporation had infringed Applied's patent'. But what amounts to an infringement? How does the court decide whether Ranbaxy can make its generic version of the antibiotic Ceftin or that Tyco has to pay such a large sum?
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kempton, L. Patent infringement. Nat Rev Drug Discov 4, 97 (2005). https://doi.org/10.1038/nrd1638
Issue date:
DOI: https://doi.org/10.1038/nrd1638
